Dr. Jeffrey R. Jay, M.D. »

Contineum Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.1M 800k 11.43

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Amylyx Pharmaceuticals (AMLX)
Zura Bio Class A Ord Shs (ZURA)
Disc Medicine (IRON)
Rapt Therapeutics Com New (RAPT)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Vor Biopharma Com New (VOR)
Dianthus Therapeutics (DNTH)
Jade Biosciences Com New (JBIO)
Kalvista Pharmaceuticals (KALV)
Contineum Therapeutics Cl A (CTNM)
Eupraxia Pharmaceuticals (EPRX)
Fulcrum Therapeutics (FULC)
Nektar Therapeutics Com New (NKTR)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Contineum Therapeutics

Suvretta Capital Management
RA Capital Management
Johnson & Johnson
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Versant Venture Management

View all funds holding Contineum Therapeutics